Delivery Order SPE2DB24D3015-SPE2DB25FGARJ
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Miebo 100% eye drop in 3ml quantities, with a ceiling value of $36,483.26. This firm fixed-price delivery order, which is not set-aside for any special contracting category, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,949.40 to AmerisourceBergen Drug Corp for supply of Miebo 100% eye drops (3mL) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $6,217.21 to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions to AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a $24,495 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop product (3ML units) on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical supplier to...
- The Defense Logistics Agency awarded a $1,448.13 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop (3ML) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $8,694.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of MIEBO 100% Eye Drop in 3ML units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for ultimate completion on July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Miebo 100% eye drop medication in 3 mL units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,325.38 with a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The order represents...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,527.73 to AmerisourceBergen Drug Corp for supply of Miebo 100% eye drops (3ml) on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $2,072.18 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a small-value delivery order under the company's larger pharmaceutical supply vehicle with DLA. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,063.67 to AmerisourceBergen Drug Corp for MIEBO 100% eye drops (3ml) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGARJDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Miebo 100% Eye Drop (3ml). This is a firm fixed price delivery order valued at $2,660.08, with an ultimate completion date of August 21, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's comprehensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains. This specific delivery order for ophthalmic medication reflects the contractor's ongoing role in supporting Department of Defense healthcare requirements through the DLA's Pharmaceutical Prime Vendor program, which enables flexible procurement of essential medical supplies for military personnel and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/20/25 |